Developing a Blended diet guideline Developing Blended Diet Guideline

Objective: EAT-10 helps to measure swallowing difficulties. It may be important for you to talk with your physician about treatment options for symptoms.

Join us for an insightful session as we trace the evolution of enteral nutrition, moving from the historical avoidance of fibre and peptides to their role as evidence-based essentials. The speakers discuss the clinical shift in perspective and explore how new innovations may support patient outcomes through improved tolerance and absorption. the event is follow up with recorded live Q&A.To download the full trial - Acceptability and tolerance study of a high‑protein semi‑elemental feed containing PHGG fibre | N+ HubTo explore more about Peptamen HN PHGG , please visit Peptamen® HN PHGG | N+ Hub

This webinar had the focus on the use of fibre supplements' in the nutritional management of patients with acute illness. The speaker, Nirouz Zarroug, discussed the impact of clinical decisions related to patient care.Note that : At the time of recording the webinar, Nirouz was working as a Clinical Specialist Dietitian at the Royal Liverpool University Hospital. She is currently employed as a Medical & Scientific Affairs Dietitian at Nestlé Nutrition and Health.

Nestlé Health Science’s Enteral Support Network held its latest Elevate Your Clinical Practice study day in London on Tuesday 17th June, 2025. Bringing together 17 dietitians from across England, the meeting was an opportunity to share practical and scientific perspectives on the role of fibre in enteral nutrition.

This case study discusses the management of a male patient with chronic pancreatitis and persistent C. difficile infection, requiring full enteral tube feeding for the majority of his admission, due to an unsafe swallow. As malabsorption and osmotic diarrhoea were problematic, a change in enteral formula was indicated.

Human milk contains bioactive components that confer protection on the newborn. These include complex carbohydrates called Human Milk Oligosaccharides (HMO). Research is revealing the full extent of the beneficial properties of HMOs.

HMOs, the third solid component of human milk, are complex structures with a high potential for specific functions. HMOs and prebiotic oligosaccharides have completely different structures, which impact on their functions. Additionally to prebiotic effects, HMOs reduces adhesion of pathogens and have immune modulator effect.

This video focuses on two of the most abundant and wellresearched human milk oligosaccharides (HMOs) - 2′FL and LNnT. It outlines their roles in supporting immune function, strengthening the gut barrier, and modulating microbiota, and how these mechanisms support with the dietary management of cow’s milk protein allergy (CMPA).

This video provides a brief overview of how human milk oligosaccharides (HMOs) support immune protection — showing how they block pathogen adhesion, promote beneficial microbiota, and help modulate epithelial and immune cell responses to strengthen earlylife immunity.

This video looks at the HMO journey—decades of scientific research that have deepened our understanding of what human milk oligosaccharides (HMOs) are and how they contribute to the development of infant immunity. It highlights how this evidence base has enabled Nestlé to incorporate key HMOs into specialist infant formulas, supporting continued innovation.

This video offers an introduction to human milk oligosaccharides (HMOs), a key component of human milk. In this introduction we look at what HMOs are, how they are formed and how their benefits are linked to their unique structures.

Learn how to develop a structured, evidence-based approach to support blended diets and enteral tube feeds with food-derived ingredients as first-line options for children requiring enteral nutrition.